(Q41994893)

15 October 2017

Relationships between medication treatments and neuropsychological test performance in schizophrenia (English)

1 reference

https://api.crossref.org/works/10.1016/0165-1781(91)90065-W

27 October 2022

1 reference

1 reference

neuropsychological tests

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1679950

27 October 2022

schizophrenic psychology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1679950

27 October 2022

1

J. A. Sweeney

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1679950

27 October 2022

author name string

J. G. Keilp

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1679950

27 October 2022

G. L. Haas

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1679950

27 October 2022

J. Hill

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1679950

27 October 2022

P. J. Weiden

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1679950

27 October 2022

language of work or name

English

0 references

publication date

1 June 1991

1 reference

full work available at URL

15 October 2017

https://api.elsevier.com/content/article/PII:016517819190065W?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0165-1781(91)90065-W

https://api.elsevier.com/content/article/PII:016517819190065W?httpAccept=text/plain

27 October 2022

1 reference

https://api.crossref.org/works/10.1016/0165-1781(91)90065-W

27 October 2022

1 reference

15 October 2017

37

1 reference

15 October 2017

3

1 reference

15 October 2017

297-308

1 reference

The Withdrawal of Benztropine Mesylate in Chronic Schizophrenic Patients

15 October 2017

3

1 reference

https://api.crossref.org/works/10.1016/0165-1781(91)90065-W

The cholinergic hypothesis of geriatric memory dysfunction

27 October 2022

5

1 reference

https://api.crossref.org/works/10.1016/0165-1781(91)90065-W

Spatial working memory in rats: effects of monoaminergic antagonists.

27 October 2022

6

1 reference

https://api.crossref.org/works/10.1016/0165-1781(91)90065-W

Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia. IV. Further evidence for regional and behavioral specificity

27 October 2022

7

1 reference

https://api.crossref.org/works/10.1016/0165-1781(91)90065-W

Cognitive Deficit Caused by Regional Depletion of Dopamine in Prefrontal Cortex of Rhesus Monkey

27 October 2022

8

1 reference

https://api.crossref.org/works/10.1016/0165-1781(91)90065-W

Defective concept formation in parkinsonians is independent from mental deterioration

27 October 2022

9

1 reference

https://api.crossref.org/works/10.1016/0165-1781(91)90065-W

The effect of neuroleptics on dysfunction in a prefrontal substrate of sustained attention in schizophrenia.

27 October 2022

10

1 reference

https://api.crossref.org/works/10.1016/0165-1781(91)90065-W

The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance

27 October 2022

12

1 reference

https://api.crossref.org/works/10.1016/0165-1781(91)90065-W

Cognitive Concomitants of Hemispheric Dysfunction in Schizophrenia

27 October 2022

13

1 reference

https://api.crossref.org/works/10.1016/0165-1781(91)90065-W

The effects of drugs on psychiatric patients' performance on the Halstead-Reitan neuropsychological test battery

27 October 2022

14

1 reference

https://api.crossref.org/works/10.1016/0165-1781(91)90065-W

Cognitive impairment in schizophrenia: Specific relations to ventricular size and negative symptomatology

27 October 2022

15

1 reference

https://api.crossref.org/works/10.1016/0165-1781(91)90065-W

Cognitive impairments associated with early Parkinson's disease.

27 October 2022

17

1 reference

https://api.crossref.org/works/10.1016/0165-1781(91)90065-W

Contributions of clinical neuropsychology to the study of schizophrenia

27 October 2022

18

1 reference

https://api.crossref.org/works/10.1016/0165-1781(91)90065-W

Central catecholamine metabolism in vivo and the cognitive and motor deficits in Parkinson's disease

27 October 2022

19

1 reference

https://api.crossref.org/works/10.1016/0165-1781(91)90065-W

Insight and the clinical outcome of schizophrenic patients

27 October 2022

20

1 reference

https://api.crossref.org/works/10.1016/0165-1781(91)90065-W

Induction of cortical cholinergic hypofunction and memory retention deficits through intracortical AF64A infusions

27 October 2022

21

1 reference

https://api.crossref.org/works/10.1016/0165-1781(91)90065-W

Schizophrenic performance when distractors are present: Attentional deficit or differential task difficulty?

27 October 2022

22

1 reference

https://api.crossref.org/works/10.1016/0165-1781(91)90065-W

Perceptual acuity and sympathetic reactivity in schizophrenia

27 October 2022

24

1 reference

https://api.crossref.org/works/10.1016/0165-1781(91)90065-W

Memory deficits and anticholinergic levels in chronic schizophrenia.

27 October 2022

25

1 reference

https://api.crossref.org/works/10.1016/0165-1781(91)90065-W

Relation of neuroleptic and anticholinergic medication to cognitive functions in schizophrenia

27 October 2022

28

1 reference

https://api.crossref.org/works/10.1016/0165-1781(91)90065-W

Psychopharmacologic and clinical correlates of attention in chronic schizophrenia

27 October 2022

29

1 reference

https://api.crossref.org/works/10.1016/0165-1781(91)90065-W

Frontal lobe dysfunction in Parkinson's disease. The cortical focus of neostriatal outflow

27 October 2022

30

1 reference

https://api.crossref.org/works/10.1016/0165-1781(91)90065-W

Serum levels of anticholinergic drugs and impaired recent memory in chronic schizophrenic patients.

27 October 2022

31

1 reference

https://api.crossref.org/works/10.1016/0165-1781(91)90065-W

Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. I. Regional cerebral blood flow evidence

27 October 2022

32

1 reference

https://api.crossref.org/works/10.1016/0165-1781(91)90065-W

27 October 2022

Identifiers

1 reference

15 October 2017

1 reference